Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05774639
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2023-02-25
Brief Title:
Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR Omalizumab in Adults With Chronic Idiopathic Urticaria
Sponsor:
Kashiv BioSciences LLC
Organization:
Kashiv BioSciences LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-15
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-04-22
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-25
First Submit QC Date:
March 7 2023
Study First Post Date:
2023-03-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-28
Last Update Post Date:
2024-07-01
Last Update Post Date Type:
ACTUAL